PREVER Study: Efficacy of the combination of Chlorthalidone and Amiloride versus placebo in the prevention of hypertension in patients with prehypertension PREVER 1 Study - PREVER 1 Study: Prevention of Cardiovascular outcomes in patients with prehypertension

Hospital de Clínicas de Porto Alegre0 个研究点开始时间: 2011年3月2日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•I. individuals with 30 to 70 years of age
•II. Systolic Arterial Pressure 120-139 mmHg or Diastolic Arterial Pressure 80-89 mmHg;

•I. Previous diagnosis of hypertension or use of antihypertensive drugs;
•II. Allergies to Chlorthalidone Amiloride;
•III. Known cardiovascular disease (previous Miocardial Infarction, previous stroke, heart failure or clinical manifestations, for example, current or previous angina, intermittent claudication ...);
•IV. Chronic diseases that limit the participation or the prospect of life (such as cancer, rheumatic disease, disability, etc.);
•V. Analgesics or anti-inflammatory use for 30 days or more;
•VI. Inability to measure blood pressure;
•VII. Difficulty in understanding that limits participation in the study;
•VIII. IF WOMEN: Pregnant or planning to become pregnant in the next two years;
•IX. Patients who have participated in other randomized trials (the last six months);

发起方

Hospital de Clínicas de Porto Alegre